Ardelyx, INC Form 4 insider transactions

Susan Hohenleitner, Chief Financial Officer of Ardelyx, Inc., sold 1,558 shares of common stock on August 21, 2026 for $3.86 per share.

Joseph James Reilly, See Remarks of Ardelyx, Inc., sold 3,982 shares of common stock on August 21, 2026 for $3.86 per share.

John E Bishop, See Remarks of Ardelyx, Inc., sold 19,750 shares of common stock on August 21, 2026 for $3.86 per share.

James Parker Brady, Chief Human Resources Officer of Ardelyx, Inc., sold 15,136 shares of common stock on August 21, 2026 for $3.86 per share.

Eric Duane Foster, Chief Commercial Officer of Ardelyx, Inc., sold 8,562 shares of common stock on August 21, 2026 for $3.86 per share.

Mike Kelliher, Chief Business Officer of Ardelyx, Inc., sold 7,758 shares of common stock on August 21, 2026 for $3.86 per share.

Laura A Williams, Chief Patient Officer of Ardelyx, Inc., sold 10,739 shares of common stock on August 21, 2026 for $3.86 per share.

Michael Raab, President & CEO and a Director of Ardelyx, Inc., sold 58,574 shares of common stock on August 21, 2026 for $3.86 per share.

Michael Raab, President & CEO and a Director of Ardelyx, Inc., sold 41,668 shares of common stock on July 15, 2026 for $5.06 per share.

Merdad Parsey, a Director at Ardelyx, Inc., reported transactions involving common stock and stock options on June 16, 2026.

Ardelyx, Inc. Director Richard J. Rodgers acquired 26,455 shares of common stock and was granted an option to purchase 39,715 shares.

Ardelyx, Inc. director David Mott acquired shares and stock options under the company's compensation program on June 16, 2026.

Onaiza Cadoret-Manier, a Director at Ardelyx, Inc., has reported transactions involving restricted stock units and stock options.

Ardelyx, Inc. Director Muna Bhanji has reported transactions involving restricted stock units and stock options, as filed with the SEC.

Director William C. Bertrand Jr. acquired shares and stock options in Ardelyx, Inc. through the company's Non-Employee Director Compensation Program.

Ardelyx, Inc. reports that Director Robert B. Bazemore acquired restricted stock units and stock options on June 16, 2026, as part of the company's Non-Employee Director Compensation Program.

Ardelyx CEO Michael Raab executed a series of stock transactions, including the acquisition of shares under a 10b5-1 plan and the disposal of other shares.

Ardelyx, Inc. Chief Accounting Officer Joseph J. Reilly sold 3,719 shares of common stock to satisfy tax obligations related to RSU vesting.

Ardelyx CFO Susan Hohenleitner sold 1,455 shares of common stock to satisfy tax withholding obligations related to RSU vesting.

Chief Technical and Quality Officer John Bishop sold 2,306 shares of Ardelyx, Inc. to satisfy tax obligations related to RSU vesting.

Ardelyx Chief Human Resources Officer James Parker Brady sold 1,846 shares of common stock to satisfy tax withholding obligations.

Chief Commercial Officer Eric Foster sold 7,998 shares of Ardelyx common stock to satisfy tax withholding obligations related to RSU vesting.

Chief Patient Officer Laura A. Williams sold 6,989 shares of Ardelyx common stock to cover tax obligations related to RSU vesting.

ARDELYX CEO Michael Raab sold 54,748 shares of common stock to cover tax obligations related to RSU vesting.

Ardelyx President & CEO Michael Raab reported transactions involving company stock, including the acquisition of shares under a 10b5-1 plan and the sale of other shares.

Ardelyx CEO Michael Raab exercised stock options and sold shares under a pre-established 10b5-1 trading plan.

ARDELYX, Inc. President and CEO Michael Raab executed a pre-planned transaction, exercising stock options and selling a portion of his common stock holdings.

ARDELYX CEO Michael Raab exercised stock options and subsequently sold a portion of common stock under a pre-arranged 10b5-1 trading plan.

ARDX Director David Mott acquired 333,333 shares of common stock at a weighted average price of $5.839 per share.

Ardelyx Chief Technical Operations Officer John Bishop sold 3,179 shares of common stock to cover tax withholding obligations related to RSU vesting.